Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin — NEJM

Retweeted NEJM (@NEJM): SAPPHIRE I: Very high SVR rates achieved in untreated, non-cirrhotic HCV w/ four oral agents. #ilc2014 http://t.co/Uz1AQgfE8O

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/Uz1AQgfE8O